McKeon, Andrew <br/><br/>
Individualized rituximab treatment for neuromyelitis Optica spectrum disorders.  [electronic resource] 

 -  JAMA neurology  Sep 2013 
 - 1103-4 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>2168-6157 
<br/><br/><label>Standard No.: </label>10.1001/jamaneurol.2013.3583  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antigens, CD19--immunology<br/>Aquaporin 4--immunology<br/>Autoantibodies--immunology<br/>B-Lymphocytes--drug effects<br/>Humans<br/>Neuromyelitis Optica--diagnosis<br/>Rituximab<br/>Tumor Necrosis Factor Receptor Superfamily, Member 7--immunology